Request a document copy: Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study

all files (of this document) in restricted access
the file(s) you requested
Cancel